U.S. MARKETS FOR INTERVENTIONAL TECHNOLOGIES FOR THE MANAGEMENT OF PERIPHERAL VASCULAR DISORDERS

273 Pages | 62 Exhibits | 2014 Analysis | Forecasts Through 2017 Product Family: Market Reports




OVERVIEW:
Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. The most commonly diagnosed form of PVD is plaque-related peripheral artery disease; among the other types of PVD are chronic venous insufficiency, deep vein thrombosis, and pulmonary embolism.

In 2012, approximately 3.8 million interventional procedures for the diagnosis and treatment of PVD were performed in the United States (U.S.), generating an estimated $1.67 billion in corresponding product sales. The number of diagnostic and therapeutic interventions for PVD management is expected to increase at a compound annual rate of 2.0% during the forecast period covered by this report, reaching nearly 4.2 million in the year 2017. Sales of products to perform these interventional procedures are projected to increase at a compound annual rate of 6.0% during the forecast period covered by this report, reaching an estimated $2.2 billion in the year 2017.

This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities in the U.S. interventional peripheral vascular disease management arena.

Covered topics in this report include angiography devices; catheter-directed thrombolysis products; drug-eluting balloon systems; cryotherapy products; endovascular embolization products; intravascular ultrasound systems; mechanical atherectomy systems; thrombectomy products; noninvasive peripheral vascular disease treatments; peripheral transluminal angioplasty devices; surgical/endoscopic peripheral vascular disease treatments; vascular puncture closure devices; and vena cava filters, among others.

TABLE OF CONTENTS:
Executive Summary

i. Interventional Peripheral Vascular Disease Diagnostic Products Market
	a. Angiography
	b. Intravascular Ultrasound
ii. Interventional Peripheral Vascular Disease Treatment Products Market
	a. Percutaneous Transluminal Angioplasty
	b. Catheter-Directed Thrombolysis
	c. Mechanical Atherectomy
	d. Endovascular Embolization
	e. Thrombectomy
	f. Vena Cava Filter Placement
	g. Vascular Puncture Hemostasis
	h. Cryotherapy
iii. Methodology

Exhibit ES-1: Interventional Peripheral Vascular Disease Management, Combined Procedure Volumes Forecast, 2012-2017
Exhibit ES-2: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, 2012-2017
Exhibit ES-3: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast,  by Segment 2012-2017
Exhibit ES-4: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2012-2017
Exhibit ES-5: Intravascular Ultrasound Catheters, Market Forecast, 2012-2017
Exhibit ES-6: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2012-2017
Exhibit ES-7: Catheter-Directed Thrombolysis Systems, Market Forecast, 2012-2017
Exhibit ES-8: Mechanical Atherectomy Systems, Market Forecast, 2012-2017
Exhibit ES-9: Endovascular Embolization Products, Market Forecast, 2012-2017
Exhibit ES-10: Thrombectomy Systems, Market Forecast, 2012-2017
Exhibit ES-11: Vena Cava Filter Systems, Market Forecast, 2012-2017
Exhibit ES-12: Vascular Puncture Closure Systems, Market Forecast, 2012-2017
Exhibit ES-13: Endovascular Cryotherapy Systems, Market Forecast, 2012-2017

1. PERIPHERAL VASCULAR DISEASE OVERVIEW

1.1 Anatomy and Physiology of the Circulatory System
1.2 Types of Peripheral Vascular Disease
	1.2.1 Peripheral Artery Disease
		1.2.1.1 Etiology
		1.2.1.2 Epidemiology
	1.2.2 Aneurysm
		1.2.2.1 Etiology
		1.2.2.2 Epidemiology
	1.2.3 Deep Vein Thrombosis and Pulmonary Embolism
		1.2.3.1 Etiology
		1.2.3.2 Epidemiology
	1.2.4 Chronic Venous Insufficiency
		1.2.4.1 Etiology
		1.2.4.2 Epidemiology

Exhibit 1-1: 2013, Peripheral Artery Disease, Facts and Figures
Exhibit 1-2: 2013, Aortic Aneurysm, Facts and Figures
Exhibit 1-3: 2013, Deep Vein Thrombosis, Facts and Figures
Exhibit 1-4: Classification of Chronic Venous Insufficiency
Exhibit 1-5: 2013, Chronic Venous Insufficiency, Facts and Figures

2. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE DIAGNOSTIC PRODUCTS MARKET

2.1 Noninvasive Peripheral Vascular Disease Diagnostics
	2.1.1 Ankle/Brachial Index
	2.1.2 Exercise Tolerance Testing
	2.1.3 Imaging Methods
		2.1.3.1 Computed Tomography
		2.1.3.2 Magnetic Resonance Imaging
		2.1.3.3 Diagnostic Ultrasound Imaging
	2.1.4 Photoplethysmography and Air Plethysmography
2.2 Interventional Peripheral Vascular Disease Diagnostics, Market Analysis
	2.2.1 Angiography
		2.2.1.1 Types
			2.2.1.1.1 Peripheral Arterial Angiography
			2.2.1.1.2 Peripheral Venous Angiography
			2.2.1.1.3 Ascending and Descending Venography
			2.2.1.1.4 Venographic Applications for Deep Vein Thrombosis in Lower and Upper Extremities
		2.2.1.2 Procedures/Technologies
		2.2.1.3 Products
		2.2.1.4 Market Forecast
		2.2.1.5 Competitors
	2.2.2 Intravascular Ultrasound
		2.2.2.1 Procedures/Technologies
		2.2.2.2 Products
		2.2.2.3 Market Forecast
		2.2.2.4 Competitors

Exhibit 2-1: Interventional Peripheral Vascular Disease Diagnosis, Combined Procedure Volumes Forecast, 2012-2017
Exhibit 2-2: Interventional Peripheral Vascular Disease Diagnostic Products, Combined Market Forecast, 2012-2017
Exhibit 2-3: Peripheral Angiography, Procedure Volumes Forecast, 2012-2017
Exhibit 2-4: 2013, Selected Angiography Catheters
Exhibit 2-5: 2013, Selected Diagnostic Guidewires
Exhibit 2-6: 2013, Selected Introducers/Sheaths
Exhibit 2-7: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2012-2017
Exhibit 2-8: 2012, Market for Angiography Devices for Peripheral Vascular Disease Diagnostics, Share by Supplier
Exhibit 2-9: Intravascular Ultrasound, Procedure Volumes Forecast, 2012-2017
Exhibit 2-10: 2013, Selected Intravascular Ultrasound Catheters and Systems
Exhibit 2-11: Intravascular Ultrasound Products, Market Forecast, 2012-2017
Exhibit 2-12: 2012, Intravascular Ultrasound Products Market, Share by Supplier

3. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE TREATMENT PRODUCTS MARKET

3.1 Noninvasive Peripheral Vascular Disease Treatments
3.2 Surgical/Endoscopic Peripheral Vascular Disease Treatments
	3.2.1 Peripheral Artery Surgery
		3.2.1.1 Aortofemoral Bypass Graft Surgery
		3.2.1.2 Distal Tibial-Peroneal Vascular Reconstruction
		3.2.1.3 Femoropopliteal Bypass Graft Surgery
	3.2.2 Thromboendarterectomy
	3.2.3 Chronic Venous Insufficiency and Venous Ulceration Treatments
		3.2.3.1 Deep Vein Reconstruction
		3.2.3.2 Open Subfascial Perforator Surgery
		3.2.3.3 Sclerotherapy
		3.2.3.4 Skin Grafting
		3.2.3.5 Subfascial Endoscopic Perforator Surgery
		3.2.3.6 Superficial Vein Stripping
3.3 Interventional Peripheral Vascular Disease Treatments, Market Analysis
	3.3.1 Percutaneous Transluminal Angioplasty
		3.3.1.1 Procedures/Technologies
		3.3.1.2 Products
			3.3.1.2.1 Balloon Catheters
			3.3.1.2.2 Guiding Catheters
			3.3.1.2.3 Guidewires
			3.3.1.2.4 Introducers/Sheaths
			3.3.1.2.5 Accessories
		3.3.1.3 Market Forecast
		3.3.1.4 Competitors
	3.3.2 Catheter-Directed Thrombolysis
		3.3.2.1 Procedures/Technologies
		3.3.2.2 Products
		3.3.2.3 Market Forecast
		3.3.2.4 Competitors
	3.3.3 Mechanical Atherectomy
		3.3.3.1 Procedures/Technologies
		3.3.3.2 Products
		3.3.3.3 Market Forecast
		3.3.3.4 Competitors
	3.3.4 Endovascular Embolization
		3.3.4.1 Procedures/Technologies
		3.3.4.2 Products
		3.3.4.3 Market Forecast
		3.3.4.4 Competitors
	3.3.5 Thrombectomy
		3.3.5.1 Procedures/Technologies
		3.3.5.2 Products
		3.3.5.3 Market Forecast
		3.3.5.4 Competitors
	3.3.6 Vena Cava Filter Placement
		3.3.6.1 Procedures/Technologies
		3.3.6.2 Products
		3.3.6.3 Market Forecast
		3.3.6.4 Competitors
	3.3.7 Vascular Puncture Hemostasis Tools and Techniques
		3.3.7.1 Procedures/Technologies
		3.3.7.2 Products
		3.3.7.3 Market Forecast
		3.3.7.4 Competitors
	3.3.8 Cryotherapy
		3.3.8.1 Procedures/Technologies
		3.3.8.2 Products
		3.3.8.3 Market Forecast

Exhibit 3-1: Interventional Peripheral Vascular Disease Treatment, Combined Procedure Volumes Forecast, 2012-2017
Exhibit 3-2: Interventional Peripheral Vascular Disease Treatment Products, Combined Market Forecast, 2012-2017
Exhibit 3-3: Percutaneous Transluminal Angioplasty, Procedure Volumes Forecast, 2012-2017
Exhibit 3-4: 2013, Selected Percutaneous Transluminal Angioplasty Balloon Catheters
Exhibit 3-5: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2012-2017
Exhibit 3-6: 2012, Percutaneous Transluminal Angioplasty Devices Market, Share by Supplier
Exhibit 3-7: Catheter-Directed Thrombolysis, Procedure Volumes Forecast, 2012-2017
Exhibit 3-8: 2013, Selected Catheter-Directed Thrombolysis Systems
Exhibit 3-9: Catheter-Directed Thrombolysis Systems,  Market Forecast, 2012-2017
Exhibit 3-10: 2012, Catheter-Directed Thrombolysis Systems Market, Share by Supplier
Exhibit 3-11: Mechanical Atherectomy, Procedure Volumes Forecast, 2012-2017
Exhibit 3-12: 2013, Selected Mechanical Atherectomy Systems
Exhibit 3-13: Mechanical Atherectomy Systems, Market Forecast, 2012-2017
Exhibit 3-14: 2012, Mechanical Atherectomy Systems, Share by Supplier
Exhibit 3-15: Endovascular Embolization, Procedure Volumes Forecast, 2012-2017
Exhibit 3-16: 2013, Selected Endovascular Embolization Products
Exhibit 3-17: Endovascular Embolization Products, Market Forecast, 2012-2017
Exhibit 3-18: 2012, Endovascular Embolization Products Market, Share by Supplier
Exhibit 3-19: Thrombectomy, Procedure Volumes Forecast, 2012-2017
Exhibit 3-20: 2013, Selected Thrombectomy Systems
Exhibit 3-21: Thrombectomy, Market Forecast, 2012-2017
Exhibit 3-22: 2012, Thrombectomy Systems Market, Share by Supplier
Exhibit 3-23: Vena Cava Filter Placement, Procedure Volumes Forecast, 2012-2017
Exhibit 3-24: 2013, Selected Vena Cava Filter Systems
Exhibit 3-25: Vena Cava Filter Systems, Market Forecast, 2012-2017
Exhibit 3-26: 2012, Vena Cava Filter Systems Market, Share by Supplier
Exhibit 3-27: Vascular Puncture Closure Systems, Procedure Volumes Forecast, 2012-2017
Exhibit 3-28: 2013, Selected Vascular Puncture Closure Systems
Exhibit 3-29: Vascular Puncture Closure Systems, Market Forecast, 2012-2017
Exhibit 3-30: 2012, Vascular Puncture Closure Systems Market, Share by Supplier
Exhibit 3-31: Endovascular Cryotherapy, Procedure Volumes Forecast, 2012-2017
Exhibit 3-32: Endovascular Cryotherapy Systems, Market Forecast, 2012-2017

4. COMPANY PROFILES

4.1 Abbott Laboratories
4.2 AccessClosure, Inc.
4.3 AngioDynamics, Inc.
4.4 Arrow International/Teleflex, Inc.
4.5 C.R. Bard, Inc.
4.6 Boston Scientific Corporation
4.7 B. Braun Melsungen AG
4.8 Cardiovascular Systems, Inc.
4.9 Cardiva Medical, Inc.
4.10 Cook Medical/Cook Group
4.11 Cordis Corporation/Johnson & Johnson
4.12 Covidien
4.13 MEDRAD, Inc./Bayer HealthCare/Bayer Group
4.14 Merit Medical Systems, Inc.
4.15 Spectranetics Corporation
4.16 St. Jude Medical, Inc.
4.17 Terumo Interventional Systems/Terumo Corporation
4.18 Volcano Corporation

APPENDIX:  COMPANY LISTING



COMPANIES COVERED:

  1. Abbott Laboratories
  2. Abbott Vascular/Abbott Laboratories
  3. AccessClosure, Inc.
  4. ALN International, Inc.
  5. AngioDynamics, Inc.
  6. AngioScore, Inc.
  7. Angiotech Pharmaceuticals, Inc.
  8. Argon Medical Devices, Inc.
  9. Arrow International, Inc./Teleflex, Inc.
  10. Arstasis, Inc.
  11. Avinger, Inc.
  12. C.R. Bard, Inc.
  13. Bayer AG
  14. Bayer HealthCare AG/Bayer AG
  15. Biocompatibles, Inc./BTG International, Ltd.
  16. Boston Scientific Corporation
  17. B. Braun Melsungen AG
  18. Cardiovascular Systems, Inc.
  19. Cardiva Medical, Inc.
  20. CeloNova Biosciences, Inc.
  21. Cook Group, Inc.
  22. Cordis Corporation/Johnson & Johnson
  23. Covidien
  24. EKOS Corporation/BTG International, Ltd.
  25. InSitu Technologies, Inc.
  26. Marine Polymer Technologies, Inc.
  27. MEDRAD/Bayer HealthCare AG/Bayer AG
  28. Medtronic, Inc.
  29. Merit Medical Systems, Inc.
  30. Morris Innovative, Inc.
  31. NuMed, Inc
  32. Spectranetics Corporation
  33. St. Jude Medical, Inc.
  34. Teleflex, Inc.
  35. Terumo Interventional Systems/Terumo Corporation
  36. Vascular Solutions, Inc.
  37. Volcano Corporation
Contact Us

Need help finding medtech research? Let us help you!